Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009375
Filing Date
2023-05-11
Accepted
2023-05-11 16:06:22
Documents
71
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rain-20230331x10q.htm   iXBRL 10-Q 1265503
2 EX-10.1 rain-20230331xex10d1.htm EX-10.1 49107
3 EX-10.2 rain-20230331xex10d2.htm EX-10.2 47812
4 EX-10.3 rain-20230331xex10d3.htm EX-10.3 54375
5 EX-10.4 rain-20230331xex10d4.htm EX-10.4 56415
6 EX-10.5 rain-20230331xex10d5.htm EX-10.5 51759
7 EX-10.6 rain-20230331xex10d6.htm EX-10.6 51861
8 EX-31.1 rain-20230331xex31d1.htm EX-31.1 13749
9 EX-31.2 rain-20230331xex31d2.htm EX-31.2 17853
10 EX-32.1 rain-20230331xex32d1.htm EX-32.1 12791
11 GRAPHIC rain-20230331x10q006.jpg GRAPHIC 40228
  Complete submission text file 0001558370-23-009375.txt   6765536

Data Files

Seq Description Document Type Size
12 EX-101.SCH rain-20230331.xsd EX-101.SCH 47396
13 EX-101.CAL rain-20230331_cal.xml EX-101.CAL 53972
14 EX-101.DEF rain-20230331_def.xml EX-101.DEF 152136
15 EX-101.LAB rain-20230331_lab.xml EX-101.LAB 457045
16 EX-101.PRE rain-20230331_pre.xml EX-101.PRE 310646
65 EXTRACTED XBRL INSTANCE DOCUMENT rain-20230331x10q_htm.xml XML 1163906
Mailing Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560
Business Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560 (510) 953-5559
Rain Oncology Inc. (Filer) CIK: 0001724979 (see all company filings)

EIN.: 821130967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40356 | Film No.: 23910964
SIC: 2834 Pharmaceutical Preparations